# Immix Biopharma, Inc.: Form 8-K, filed Jul 22, 2024

- Company: [Immix Biopharma, Inc.](/companies/immx.md) (CIK 1873835)
- Form: 8-K
- Filed: 2024-07-22
- Accepted by EDGAR: Jul 19, 2024, 21:20 ET
- Period: 2024-07-17
- Accession: 0001493152-24-028595
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/form8-k.htm

Filed Jul 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-028595. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.